Innovus Pharmaceuticals amends maturity of $162,668 of convertibles

Convertible debentures now will mature on Jan. 13, 2014

By Devika Patel

Knoxville, Tenn., Jan. 30 - Innovus Pharmaceuticals, Inc. amended its $162,668 of 8% convertible debentures on Jan. 29, according to an 8-K filed Wednesday with the Securities and Exchange Commission. The notes were issued in January.

The debentures will now mature on Jan. 13, 2014.

The pharmaceutical company is based in San Diego.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.